Multidisciplinary Delphi Consensus on the Clinical Use of Intranasal Carboxymethyl-β-Glucan-Resveratrol: Evidence-Based Recommendations for Upper Airway Diseases
This multidisciplinary Delphi Consensus provides evidence-based recommendations for the use of intranasal CMBG-resveratrol to manage upper airway diseases, particularly respiratory infections and allergic rhinitis. The formulation's multitarget approach addresses the complex pathophysiology of these conditions through simultaneous antimicrobial (mainly antiviral), anti-inflammatory, and immunomodulatory effects.
Authors
- Germano Bettoncelli (ORCID: https://orcid.org/0000-0001-8883-0794)
- La Mantia
- Matteo Gelardi (ORCID: https://orcid.org/0000-0003-4406-0008)
- Giorgio Ciprandi (ORCID: https://orcid.org/0000-0001-7016-8421)
- Paola Mastromarino (ORCID: https://orcid.org/0000-0002-8529-0216)
- Michele Miraglia del Giudice (ORCID: https://orcid.org/0000-0002-8369-5957)
- Oliviero Rossi
- Giovanni Arturo Rossi
- Attilio Varricchio
Institutions
- University of Foggia (IT)
- University of Molise (IT)
- Università degli Studi di Enna Kore (IT)
- Istituto Giannina Gaslini (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- University of Brescia (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-04-17
- DOI
- https://doi.org/10.3390/jcm15083087
- Primary Topic
- Pediatric health and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00